{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:24:00Z","timestamp":1786994640895,"version":"build-2736575974"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T00:00:00Z","timestamp":1747267200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Non-coding RNA Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ncrna.2025.05.009","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T19:38:40Z","timestamp":1747337920000},"page":"174-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Role of Ocrelizumab in modulating gene and microRNA expression in multiple sclerosis"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9132-5569","authenticated-orcid":false,"given":"Bruna","family":"De Felice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Signoriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Montanino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Archetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Maida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Marciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bonavita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Lus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1790-0374","authenticated-orcid":false,"given":"Federica","family":"Farinella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Coppola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.ncrna.2025.05.009_bib1","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s40263-022-00965-7","article-title":"High-efficacy therapies for treatment-na\u00efve individuals with relapsing\u2013remitting multiple sclerosis","volume":"36","author":"Freeman","year":"2022","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.ncrna.2025.05.009_bib2","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ncrna.2025.05.009_bib3","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s10072-016-2801-9","article-title":"Estimated prevalence of multiple sclerosis in Italy in 2015","volume":"38","author":"Battaglia","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ncrna.2025.05.009_bib4","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/ana.21141","article-title":"Environmental risk factors for multiple sclerosis. Part II: noninfectious factors","volume":"61","author":"Ascherio","year":"2007","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ncrna.2025.05.009_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-pathol-052920-040318","article-title":"The immune response in multiple sclerosis","volume":"17","author":"Rodr\u00edguez Mur\u00faa","year":"2022","journal-title":"Annu. Rev. Pathol."},{"issue":"6","key":"10.1016\/j.ncrna.2025.05.009_bib6","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S1474-4422(21)00063-6","article-title":"Cellular immunology of relapsing multiple sclerosis: interactions, checks, and balances","volume":"20","author":"Bar-Or","year":"2021","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.ncrna.2025.05.009_bib7","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a029025","article-title":"Effector T cells in multiple sclerosis","volume":"8","author":"Kaskow","year":"2018","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.ncrna.2025.05.009_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.717922","article-title":"Non-coding RNAs in the pathogenesis of multiple sclerosis","volume":"12","author":"Yousuf","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.ncrna.2025.05.009_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111528","article-title":"MicroRNA: a signature for cancer progression","volume":"138","author":"Hussen","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ncrna.2025.05.009_bib10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molimm.2019.04.011","article-title":"Long non-coding RNA: classification, biogenesis and functions in blood cells","volume":"112","author":"Dahariya","year":"2019","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.ncrna.2025.05.009_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13148-018-0586-9","article-title":"Noncoding RNAs in multiple sclerosis","volume":"10","author":"Yang","year":"2018","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.ncrna.2025.05.009_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577347","article-title":"The emerging role of lncRNAs in multiple sclerosis","volume":"347","author":"Ghaderian","year":"2020","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.ncrna.2025.05.009_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.967157","article-title":"Expression of T cell-related lncRNAs in multiple sclerosis","volume":"13","author":"Dadyar","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.ncrna.2025.05.009_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145236","article-title":"The expression analyses of RMRP, DDX5, and RORC in RRMS patients treated with different drugs versus na\u00efve patients and healthy controls","volume":"769","author":"Rahmani","year":"2021","journal-title":"Gene"},{"issue":"10","key":"10.1016\/j.ncrna.2025.05.009_bib15","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3390\/brainsci10100758","article-title":"Anti-cd20 agents for multiple sclerosis: spotlight on ocrelizumab and ofatumumab","volume":"10","author":"Florou","year":"2020","journal-title":"Brain Sci."},{"issue":"1","key":"10.1016\/j.ncrna.2025.05.009_bib16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2217\/nmt-2021-0058","article-title":"Updates and advances in multiple sclerosis neurotherapeutics","volume":"13","author":"Amin","year":"2023","journal-title":"Neurodegener. Dis. Manag."},{"issue":"December","key":"10.1016\/j.ncrna.2025.05.009_bib17","doi-asserted-by":"crossref","first-page":"1234869","DOI":"10.3389\/fimmu.2023.1234869","article-title":"Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing\u2013remitting multiple sclerosis patients","volume":"14","author":"Arisi","year":"2023","journal-title":"Front. Immunol."},{"issue":"7825","key":"10.1016\/j.ncrna.2025.05.009_bib18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-020-2649-2","article-title":"Array programming with NumPy","volume":"585","author":"Harris","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ncrna.2025.05.009_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ncrna.2025.05.009_bib20","series-title":"Proceedings of the 9th Python in Science Conference","doi-asserted-by":"crossref","first-page":"56","DOI":"10.25080\/Majora-92bf1922-00a","article-title":"Data structures for statistical computing in Python","author":"McKinney","year":"2010"},{"issue":"3","key":"10.1016\/j.ncrna.2025.05.009_bib21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1109\/MCSE.2007.55","article-title":"Matplotlib: a 2D graphics environment","volume":"9","author":"Hunter","year":"2007","journal-title":"Comput. Sci. Eng."},{"issue":"60","key":"10.1016\/j.ncrna.2025.05.009_bib22","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.21105\/joss.03021","article-title":"Seaborn: statistical data visualization","volume":"6","author":"Waskom","year":"2021","journal-title":"J. Open Source Softw."},{"issue":"D1","key":"10.1016\/j.ncrna.2025.05.009_bib23","doi-asserted-by":"crossref","first-page":"D189","DOI":"10.1093\/nar\/gkz804","article-title":"RNAInter in 2020: RNA interactome repository with increased coverage and annotation","volume":"48","author":"Lin","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.ncrna.2025.05.009_bib24","doi-asserted-by":"crossref","first-page":"D326","DOI":"10.1093\/nar\/gkab997","article-title":"RNAInter v4.0: RNA interactome repository with redefined confidence scoring system and improved accessibility","volume":"50","author":"Kang","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"7803","key":"10.1016\/j.ncrna.2025.05.009_bib25","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41586-020-2188-x","article-title":"A reference map of the human binary protein interactome","volume":"580","author":"Luck","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ncrna.2025.05.009_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang","year":"2009","journal-title":"Nat. Protoc."},{"issue":"W1","key":"10.1016\/j.ncrna.2025.05.009_bib27","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"Sherman","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"W1","key":"10.1016\/j.ncrna.2025.05.009_bib28","doi-asserted-by":"crossref","first-page":"W191","DOI":"10.1093\/nar\/gkz369","article-title":"G:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update)","volume":"47","author":"Raudvere","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"22","key":"10.1016\/j.ncrna.2025.05.009_bib29","first-page":"426","article-title":"Cytoscape: a software environment for integrated models","volume":"13","author":"Shannon","year":"1971","journal-title":"Genome Res."},{"issue":"11","key":"10.1016\/j.ncrna.2025.05.009_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0013984","article-title":"Enrichment map: a network-based method for gene-set enrichment visualization and interpretation","volume":"5","author":"Merico","year":"2010","journal-title":"PLoS One"},{"issue":"Suppl 4","key":"10.1016\/j.ncrna.2025.05.009_bib31","doi-asserted-by":"crossref","first-page":"S11.","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","volume":"8","author":"Chin","year":"2014","journal-title":"BMC Syst. Biol."},{"issue":"3","key":"10.1016\/j.ncrna.2025.05.009_bib32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/WCO.0000000000000206","article-title":"Classification, diagnosis, and differential diagnosis of multiple sclerosis","volume":"28","author":"Sand","year":"2015","journal-title":"Curr. Opin. Neurol."},{"issue":"78","key":"10.1016\/j.ncrna.2025.05.009_bib33","first-page":"4598","article-title":"Treatment of multiple sclerosis","volume":"12","author":"Izquierdo","year":"2019","journal-title":"Medicine (Spain)"},{"issue":"3","key":"10.1016\/j.ncrna.2025.05.009_bib34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ncrna.2025.05.009_bib35","first-page":"30","article-title":"Ocrelizumab versus placebo in primary progressive multiple sclerosis","volume":"18","author":"Riederer","year":"2017","journal-title":"J. fur Neurol. Neurochirur. Psychiatr."},{"key":"10.1016\/j.ncrna.2025.05.009_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105594","article-title":"NEDA-3 achievement in early highly active relapsing remitting multiple sclerosis patients treated with Ocrelizumab or Natalizumab","volume":"87","author":"Signoriello","year":"2024","journal-title":"Mult. Scler Relat. Disord."},{"issue":"2\u20133","key":"10.1016\/j.ncrna.2025.05.009_bib37","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.mam.2012.05.003","article-title":"The SLC16 gene family-Structure, role and regulation in health and disease","volume":"34","author":"Halestrap","year":"2013","journal-title":"Mol. Aspect. Med."},{"issue":"1","key":"10.1016\/j.ncrna.2025.05.009_bib38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.tibs.2020.07.005","article-title":"SLC16 family: from atomic structure to human disease","volume":"46","author":"Bosshart","year":"2021","journal-title":"Trends Biochem. Sci."},{"issue":"8","key":"10.1016\/j.ncrna.2025.05.009_bib39","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ncrna.2025.05.009_bib40","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.msard.2016.12.001","article-title":"No evidence of disease activity (NEDA) in MS should include CSF biology \u2014 towards a \u2018Disease-Free Status Score\u2019","volume":"11","author":"Bonnan","year":"2017","journal-title":"Mult. Scler Relat. Disord."},{"issue":"9","key":"10.1016\/j.ncrna.2025.05.009_bib41","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1212\/WNL.0000000000003653","article-title":"Serum neurofilament is associated with progression of brain atrophy and disability in early MS","volume":"88","author":"Kuhle","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncrna.2025.05.009_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1073\/pnas.2114406119","article-title":"Pathogenic TNF-\u03b1 drives peripheral nerve inflammation in an Aire-deficient model of autoimmunity","volume":"119","author":"Wang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ncrna.2025.05.009_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20030407","article-title":"Principles of interleukin (IL)-6-type cytokine signalling and its regulation","volume":"374","author":"Heinrich","year":"2003","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.ncrna.2025.05.009_bib44","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cyto.2015.01.009","article-title":"Seeking balance: potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10","volume":"73","author":"Ireland","year":"2015","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.ncrna.2025.05.009_bib45","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/nyas.12821","article-title":"Immunomodulatory properties of the IL-6 cytokine family in multiple sclerosis","volume":"1351","author":"Janssens","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"2","key":"10.1016\/j.ncrna.2025.05.009_bib46","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cell.2011.09.041","article-title":"An extensive MicroRNA-mediated network of RNA-RNA interactions regulates established oncogenic pathways in glioblastoma","volume":"147","author":"Sumazin","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ncrna.2025.05.009_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002484","article-title":"The viral and cellular microRNA targetome in lymphoblastoid cell lines","volume":"8","author":"Skalsky","year":"2012","journal-title":"PLoS Pathog."},{"issue":"24","key":"10.1016\/j.ncrna.2025.05.009_bib48","doi-asserted-by":"crossref","first-page":"21401","DOI":"10.1074\/jbc.M110.198630","article-title":"miR-365, a novel negative regulator of interleukin-6 gene expression, is cooperatively regulated by Sp1 and NF-\u03baB","volume":"286","author":"Xu","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.ncrna.2025.05.009_bib49","doi-asserted-by":"crossref","first-page":"8256","DOI":"10.1074\/jbc.M607712200","article-title":"The microRNA let-7a modulates interleukin-6-dependent STAT-3 survival signaling in malignant human cholangiocytes","volume":"282","author":"Meng","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ncrna.2025.05.009_bib50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/ana.20554","article-title":"A pilot proteomic study of amyloid precursor interactors in Alzheimer's disease","volume":"58","author":"Cottrell","year":"2005","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.ncrna.2025.05.009_bib51","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.cell.2014.10.050","article-title":"A proteome-scale map of the human interactome network","volume":"159","author":"Rolland","year":"2014","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.ncrna.2025.05.009_bib52","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3390\/v12060643","article-title":"Role of Viruses in the Pathogenesis of Multiple Sclerosis","volume":"12","author":"Tarlinton","year":"2020","journal-title":"Viruses"},{"issue":"December","key":"10.1016\/j.ncrna.2025.05.009_bib53","doi-asserted-by":"crossref","first-page":"587078","DOI":"10.3389\/fimmu.2020.587078","article-title":"Epstein-barr virus and multiple sclerosis","volume":"11","author":"Houen","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.ncrna.2025.05.009_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.696","article-title":"The innovative development in interferon beta treatments of relapsing-remitting multiple sclerosis","volume":"7","author":"Madsen","year":"2017","journal-title":"Brain Behav."},{"issue":"1","key":"10.1016\/j.ncrna.2025.05.009_bib55","doi-asserted-by":"crossref","DOI":"10.1186\/s11658-022-00317-9","article-title":"MicroRNA let-7 and viral infections: focus on mechanisms of action","volume":"27","author":"Letafati","year":"2022","journal-title":"Cell Mol. Biol. Lett."},{"issue":"July","key":"10.1016\/j.ncrna.2025.05.009_bib56","doi-asserted-by":"crossref","first-page":"904775","DOI":"10.3389\/fcimb.2022.904775","article-title":"MicroRNA let-7 suppresses Influenza A virus infection by targeting RPS16 and enhancing type I interferon response","volume":"12","author":"Wu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"August","key":"10.1016\/j.ncrna.2025.05.009_bib57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/ane.12845","article-title":"Fluid biomarkers for microglial activation and axonal injury in multiple sclerosis","volume":"136","author":"Zetterberg","year":"2017","journal-title":"Acta Neurol. Scand."},{"issue":"2","key":"10.1016\/j.ncrna.2025.05.009_bib58","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.brainresrev.2004.12.020","article-title":"Hormone regulation of microglial cell activation: relevance to multiple sclerosis","volume":"48","author":"Drew","year":"2005","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"4","key":"10.1016\/j.ncrna.2025.05.009_bib59","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.neuron.2020.08.012","article-title":"Astrocyte crosstalk in CNS inflammation","volume":"108","author":"Linnerbauer","year":"2020","journal-title":"Neuron"},{"issue":"9","key":"10.1016\/j.ncrna.2025.05.009_bib60","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/jnnp-2023-331051","article-title":"Association of serum neurofilament light with microglial activation in multiple sclerosis","volume":"94","author":"Saraste","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"}],"container-title":["Non-coding RNA Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054025000575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054025000575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T23:11:15Z","timestamp":1754003475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468054025000575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":60,"alternative-id":["S2468054025000575"],"URL":"https:\/\/doi.org\/10.1016\/j.ncrna.2025.05.009","relation":{},"ISSN":["2468-0540"],"issn-type":[{"value":"2468-0540","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Ocrelizumab in modulating gene and microRNA expression in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Non-coding RNA Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncrna.2025.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}